TargetMol

Monatepil maleate

Product Code:
 
TAR-T25828
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T25828-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25828-50mg50mg£1,661.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T25828-100mg100mg£2,079.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Monatepil maleate is an Antihypertensive agent. It is a calcium antagonist with alpha(1)-adrenergic receptor blocking activity
CAS:
132046-06-1
Formula:
C32H34FN3O5S
Molecular Weight:
591.7
Purity:
0.98
SMILES:
OC(=O)C=C/C(O)=O.Fc1ccc(cc1)N1CCN(CCCC(=O)NC2c3ccccc3CSc3ccccc23)CC1

References

1. Liu MH, Floten SH, Yang Q, He GW. Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts. Br J Clin Pharmacol. 2001 Sep;52(3):279-87. PubMed PMID: 11560560; PubMed Central PMCID: PMC2014550. 2. Singh NK, Goyal RK. New classes of antihypertensive drugs: therapeutic potentials. Clin Exp Hypertens. 1999 Jan-Feb;21(1-2):137-43. Review. PubMed PMID: 10052649. 3. Ikeno A, Sumiya T, Minato H, Fujitani B, Masuda Y, Hosoki K, Kurono M, Yasuba M. Effects of monatepil maleate, a new Ca2+ channel antagonist with alpha1-adrenoceptor antagonistic activity, on cholesterol absorption and catabolism in high cholesterol diet-fed rabbits. Jpn J Pharmacol. 1998 Nov;78(3):303-12. PubMed PMID: 9869264. 4. Matsunaga A, Inoue T, Koga T, Mori K, Kugi M, Sasaki J, Arakawa K. Effects of monatepil, a novel calcium antagonist with alpha 1-adrenergic blocking activity, on the low-density lipoprotein receptor in human skin fibroblasts. Cardiovasc Drugs Ther. 1997 Dec;11(6):747-50. PubMed PMID: 9512869.